FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine

FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
Thu, 30 Sep 2010 13:00:00 -0500

The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF).

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420